Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA, Cardiac Safety Research Consortium To Develop AF Ablation Registry

This article was originally published in The Gray Sheet

Executive Summary

A consortium of academics, manufacturers and government agencies plans to launch a national atrial fibrillation ablation registry, based on input from a variety of stakeholders at a meeting April 27 and 28 at FDA's White Oak, Md., headquarters

You may also be interested in...



SAFARI So Good: National Atrial Fibrillation Ablation Registry Takes Shape

As efforts to create a national atrial fibrillation ablation registry pick up steam, developers are wrestling with questions of what data elements to collect and how the information ought to be used

SAFARI So Good: National Atrial Fibrillation Ablation Registry Takes Shape

As efforts to create a national atrial fibrillation ablation registry pick up steam, developers are wrestling with questions of what data elements to collect and how the information ought to be used

MedCAC Calls For More Research On Catheter Ablation For Atrial Fibrillation

More evidence is needed to determine the benefits of using catheter ablation for treating atrial fibrillation, especially in the frail elderly population, according to the Medicare Evidence Development and Coverage Advisory Committee

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027384

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel